医学
糖尿病
入射(几何)
1型糖尿病
2型糖尿病
泊松回归
人口
内科学
人口学
切断
流行病学
胃肠病学
内分泌学
数学
物理
几何学
环境卫生
量子力学
社会学
作者
Hatice Isik Mizrak,Tine W. Hansen,Peter Rossing,Viktor Rotbain Curovic,Dorte Vistisen,Hanan Amadid,Christian Stevns Hansen
出处
期刊:Diabetes Care
[American Diabetes Association]
日期:2023-08-30
卷期号:46 (11): 1997-2003
被引量:5
摘要
OBJECTIVE It is not known if incidence rates for diabetic distal symmetric polyneuropathy (DSPN) are decreasing, as they are for other diabetic complications. Here, we investigated incidence rates of DSPN in type 1 and type 2 diabetes in a large population-based study. RESEARCH DESIGN AND METHODS In the period 1996 to 2018, 19,342 individuals were identified at a Danish tertiary diabetes center. Vibration perception threshold was assessed by biothesiometry and repeated throughout the study. Exclusion of prevalent DSPN cases or missing data left data on 9,473 individuals for analysis of DSPN using a cutoff of >25 V and on 2,783 individuals for analysis using an age-, sex-, and height-specific cutoff. Poisson regression analysis was used to model incidence rates of DSPN for both cutoff types and separately for diabetes types. Covariates were sex, age, diabetes duration, and calendar time. RESULTS Incidence rates (95% CI) of DSPN decreased from 1996 to 2018 (e.g., from 4.78 [3.60–6.33]/100 person-years [PY] to 1.15 [0.91–1.47]/100 PY for 40-year-old men with type 1 diabetes and from 16.54 [11.80–23.18]/100 PY to 8.02 [6.63–9.69]/100 PY for 60-year-old men with type 2 diabetes, when using >25 V as the cutoff value). Analyses using age-, sex-, and height-specific cutoff values demonstrated similar incidence patterns by calendar time without sex differences. For type 1 diabetes, decreasing incidence rates were seen with older age. CONCLUSIONS Incidence rates for DSPN are declining in type 1 and type 2 diabetes, possibly due to improved diabetes treatment. This causality remains to be explored. Distinct age-related patterns indicate that the pathophysiology of DSPN may differ between diabetes types.
科研通智能强力驱动
Strongly Powered by AbleSci AI